Company Encyclopedia
View More
name
Osteopore Ltd.
OSX.AU
News
View More

Osteopore Ltd. Announces Change in Substantial Holding

Osteopore Ltd. (AU:OSX) announced that Advance Opportunities Fund I is no longer a substantial holder in the company due to an indirect sale of shares. This change may affect market dynamics and stakeholder perceptions regarding the company's financial stability and investor confidence. The current market cap of Osteopore Ltd. is A$2.37M, with an average trading volume of 1,910,266 and a technical sentiment signal indicating a strong sell.

Tip Ranks·
Tip Ranks·

Osteopore Ltd. Sees Change in Substantial Shareholder Interests

Osteopore Ltd. (AU:OSX) announced a change in substantial shareholder interests, with Advance Opportunities Fund I reducing its voting power from 8.25% to 7.15% after selling 2,000,000 shares. This shift may influence the company's market dynamics and stakeholder interests, indicating a change in investment strategy by a key shareholder. The current market cap of Osteopore Ltd. is A$2.01M, with an average trading volume of 3,083,593 and a technical sentiment signal of Strong Sell.

Tip Ranks·
Tip Ranks·

Advance Opportunities Fund I Ceases Substantial Holding in Osteopore Ltd.

Advance Opportunities Fund I has ceased to be a substantial holder in Osteopore Ltd. (AU:OSX), following the sale of a significant number of shares. This change may impact the company's market dynamics and stakeholder interests. Osteopore Ltd. currently has an average trading volume of 2,998,205 and a market cap of A$2.43M, with a technical sentiment signal indicating a strong sell.

Tip Ranks·
Tip Ranks·

Osteopore Advances with Additional Funding for Growth

Osteopore Ltd. has announced an additional A$500,000 drawdown of Tranche 1 of their redeemable convertible notes, aimed at supporting its ordinary business activities and future developments in the regenerative medicine sector. This funding will enhance Osteopore's market position as a leader in 3D-printed biomimetic and bioresorbable implants, which aid in natural bone healing. The company's current market cap stands at A$2.6M, with an average trading volume of 2,803,677 shares.

Tip Ranks·
Tip Ranks·

00:00 ET Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership

Kelyniam Global, Inc. (OTC: KLYG) announced its Q1 2025 financial results, reporting a 34.7% decrease in total revenue to $624,910 and an operating loss of $(140,556). The company attributed the decline to seasonal variability and surgical schedule delays. To enhance growth, Kelyniam has formed a three-year distribution agreement with Osteopore Ltd. to distribute bioresorbable products in the U.S. The company aims to improve performance through strategic partnerships and an expanded sales team. Kelyniam will discuss these results at its Annual Shareholder Meeting on June 23, 2025.

prnewswire·
prnewswire·